Cefprozil how supplied

Jump to navigation Jump to search
Cefprozil
CEFZIL®,CEFPROZIL® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
Clinical Studies
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Cefprozil Tablets USP, 250 mg are oval-shaped, white to cream tinged, unscored, film-coated tablets, debossed 347 on one side and 250 on the reverse side and are supplied as follows:

NDC 0781-5043-01 in bottles of 100 tablets

Ceprozil Tablets USP, 500 mg are oval-shaped, beige, unscored, film-coated tablets, debossed 348 on one side and 500 on the reverse side and are supplied as follows:

NDC 0781-5044-50 in bottles of 50 tablets

NDC 0781-5044-01 in bottles of 100 tablets

Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].

Dispense in a tight, light-resistant container as defined in the USP.

Cefprozil for Oral Suspension, USP, 125 mg/5 mL is supplied as follows:

NDC 0781-6202-91 50 mL bottle

NDC 0781-6202-57 75 mL bottle

NDC 0781-6202-46 100 mL bottle

Cefprozil for Oral Suspension, USP, 250 mg/5 mL is supplied as follows:

NDC 0781-6203-91 50 mL bottle

NDC 0781-6203-57 75 mL bottle

NDC 0781-6203-46 100 mL bottle

All powder formulations for oral suspension contain cefprozil in a fruity flavored mixture. Cefprozil powder is slightly cream tinged to beige. After reconstitution the suspension is light orange and of a fruity odor and flavor.


References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050664s024,050665s024lbl.pdf